84 related articles for article (PubMed ID: 22511398)
1. Ursolic acid inhibits acid sphingomyelinase in intestinal cells.
Zhang P; Cheng Y; Duan RD
Phytother Res; 2013 Feb; 27(2):173-8. PubMed ID: 22511398
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.
Chen Y; Xu SC; Duan RD
Lipids Health Dis; 2015 Oct; 14():130. PubMed ID: 26493087
[TBL] [Abstract][Full Text] [Related]
3. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells.
Wu J; Cheng Y; Nilsson A; Duan RD
Carcinogenesis; 2004 Aug; 25(8):1327-33. PubMed ID: 15016655
[TBL] [Abstract][Full Text] [Related]
4. Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells.
Zhang Y; Duan RD
Lipids Health Dis; 2009 Dec; 8():51. PubMed ID: 19951413
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase.
Andersson D; Liu JJ; Nilsson A; Duan RD
Anticancer Res; 2003; 23(4):3317-22. PubMed ID: 12926069
[TBL] [Abstract][Full Text] [Related]
6. Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats.
Andersson D; Cheng Y; Duan RD
J Cancer Res Clin Oncol; 2008 Jan; 134(1):101-7. PubMed ID: 17605045
[TBL] [Abstract][Full Text] [Related]
7. Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells.
Cheng Y; Kozubek A; Ohlsson L; Sternby B; Duan RD
Planta Med; 2007 Jul; 73(8):725-30. PubMed ID: 17583825
[TBL] [Abstract][Full Text] [Related]
8. Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice.
Zhang P; Li B; Gao S; Duan RD
Anticancer Res; 2008; 28(6A):3631-5. PubMed ID: 19189644
[TBL] [Abstract][Full Text] [Related]
9. Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells.
Hertervig E; Nilsson A; Cheng Y; Duan RD
J Cancer Res Clin Oncol; 2003 Oct; 129(10):577-82. PubMed ID: 12920578
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.
Liu F; Cheng Y; Wu J; Tauschel HD; Duan RD
Cancer Lett; 2006 Apr; 235(1):141-6. PubMed ID: 16290921
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
[TBL] [Abstract][Full Text] [Related]
12. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice.
Cheng Y; Ohlsson L; Duan RD
Br J Nutr; 2004 May; 91(5):715-23. PubMed ID: 15137923
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity.
Wu J; Liu F; Nilsson A; Duan RD
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G967-73. PubMed ID: 15205117
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.
Cheng Y; Liu F; Wu J; Zhang Y; Nilsson A; Duan RD
Lipids; 2009 Oct; 44(10):897-906. PubMed ID: 19777283
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid suppresses IL-6 induced C-reactive protein expression in HepG2 and protects HUVECs from injury induced by CRP.
Lv YY; Jin Y; Han GZ; Liu YX; Wu T; Liu P; Zhou Q; Liu KX; Sun HJ
Eur J Pharm Sci; 2012 Jan; 45(1-2):190-4. PubMed ID: 22108347
[TBL] [Abstract][Full Text] [Related]
16. Neutral sphingomyelinase.
Chatterjee S
Adv Lipid Res; 1993; 26():25-48. PubMed ID: 8379453
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of sphingomyelin analogues as a sphingomyelinase inhibitor and the application as a blocking agent of extracellular stress signaling].
Tsuji Y; Soeda S; Ochiai T; Mishima K; Iwasaki K; Fujiwara M; Yokomatsu T; Murano T; Akiyama T; Shibuya S; Shimeno H
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):67P-69P. PubMed ID: 12491783
[TBL] [Abstract][Full Text] [Related]
18. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
[TBL] [Abstract][Full Text] [Related]
19. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S
Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462
[TBL] [Abstract][Full Text] [Related]
20. Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity.
Duan RD; Nilsson A
Hepatology; 1997 Oct; 26(4):823-30. PubMed ID: 9328299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
